Prosecution Insights

Browse Companies Examiners Firms Draft Your Response

Last updated: August 18, 2026

Examiner: BLUMEL, BENJAMIN P

Tech Center 1600 • Art Units: 1600 1648 1671

This examiner grants 71% of resolved cases

Performance Statistics

70.7%

Allow Rate

+10.7% vs TC avg

1,080

Total Applications

+30.6%

Interview Lift

1154

Avg Prosecution Days

Based on 1037 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%

§101 Eligibility

14.8%

§102 Novelty

32.4%

§103 Obviousness

29.4%

§112 Clarity

Currently Pending Office Actions

App #	Title	Status	Assignee
18282991	FLUOROGENIC SENSORS FOR DETECTING ANTIGENS	Non-Final OA	President and Fellows of Harvard College
18547976	EXTRACELLULAR VESICLE-BASED NANOCARRIERS	Non-Final OA	OHIO STATE INNOVATION FOUNDATION
18166743	MANNOSE CONJUGATED CHITOSAN-BASED INFLUENZA NANOVACCINE FORMULATIONS AND USES THEREOF	Final Rejection	Ohio State Innovation Foundation
18660408	VIRUS PURIFICATION METHOD	Non-Final OA	AGC INC.
18643793	MOLECULAR VACCINES FOR INFECTIOUS DISEASE	Non-Final OA	Agilent Technologies, Inc.
18076315	OMICRON SARS-COV-2 ASSAY	Final Rejection	Board of Regents, The University of Texas System
18749120	ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY	Non-Final OA	Purdue Research Foundation
17760180	POLYPEPTIDES AND THEIR USE	Final Rejection	University of Washington
17916323	INFLUENZA VACCINES	Final Rejection	Cambridge Enterprise Limited
18463099	IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF	Final Rejection	GLAXOSMITHKLINE BIOLOGICALS SA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy